{"symbol":"PFE","fiscalQuarter":"Q3-2016","reportDate":"2016-11-01","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q3-2016","postBrief":{"headline":"Pfizer Misses on EPS, Stock Down 2.02%","keyNumbers":[{"metric":"EPS","actual":"$0.61","expected":"N/A","surprise":"-1.61%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management expressed concerns about market conditions affecting performance.","They highlighted ongoing challenges in product sales.","No specific guidance was provided for future quarters."],"summary":"Management acknowledged the difficulties faced in the current market environment. They did not offer any updates on future performance expectations."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report indicates a slight miss on EPS, which contributed to a 2.02% decline in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. The defensive tone from management suggests they are cautious about market conditions moving forward.","metaDescription":"Pfizer Inc (PFE) Q3 2016 earnings: EPS missed expectations. Stock down 2.02%. Full breakdown."}}